Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
clinical trials
4
×
deals
4
×
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
4
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
affordable care act
amgen
bristol-myers squibb
cancer
cancer drugs
cancer immunotherapy
drug prices
What
bio
roundup
companies
hasn’t
new
alzheimer’s
appetite
approval
arrival
biogen’s
biopharmaceutical
biotech
black
bread
butter
buyout
cancer
cash
congress
convo
days
democrats
diabetes
diamond’s
divided
drug
drugs
earlier
elections
eli
failures
fallout
giant
grabbed
hold
industry
ipo
ipos
life
lilly's
Language
unset
Current search:
medicare
×
photo
×
deals
×
" san francisco top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel